NIR-II photothermal material reverses cancer multidrug resistance
Summary
NIR-II photothermal material reverses cancer multidrug resistance
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
USE OF NIR-II PHOTOTHERMAL MATERIAL IN PREPARATION OF DRUG FOR REVERSING MULTIDRUG RESISTANCE OF CANCER CELLS
Publication EP2023169546A1 Kind: A1 Mar 25, 2026
Applicants
South China University of Technology
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
A61K 41/00 20200101AFI20230915BHEP A61K 9/14 20060101ALI20230915BHEP A61K 47/24 20060101ALI20230915BHEP A61P 35/00 20060101ALI20230915BHEP C07D 513/04 20060101ALI20230915BHEP C09K 11/06 20060101ALI20230915BHEP A61K 47/69 20170101ALI20230915BHEP A61K 47/59 20170101ALI20230915BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.